Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom
Date
2006
Authors
Morgan, S.
McMahon, M.
Mitton, C.
Roughead, E.E.
Kirk, R.
Kanavos, P.
Menon, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Health Affairs, 2006; 25(2):337-347
Statement of Responsibility
Conference Name
Abstract
Many countries have centralized the clinical and economic assessments necessary for evidence-based drug coverage policy. We analyze such processes in Australia, Canada, New Zealand, and the United Kingdom. These countries apply comparable approaches to the assessment and appraisal of evidence but apply the processes to different types of drugs and use the reviews within different decision-making contexts. Review processes applied to all medicines and clearly tied to coverage decisions appear to influence national drug use. Rigor of process and transparency of data and rationale are believed to be important for maximizing the impact and political acceptability of the processes.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright status unknown